Rucaparib Recruiting Phase 3 Trials for Fallopian Tube Cancer / FIGO Stage III-IV / Partial Response / Newly Diagnosed / Complete Response / Primary Peritoneal / Ovarian Epithelial Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03522246A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy